Adjuvant chemotherapy for stage III colon cancer: relative dose intensity and survival among veterans

BACKGROUND: Given the paucity of information on dose intensity, the objective of this study is to describe the use of adjuvant chemotherapy for stage III colon cancer, focusing on relative dose intensity (RDI), overall survival (OS) and disease-free survival (DFS). METHODS: Retrospective cohort of 3...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Cancer
Autors principals: Aspinall, Sherrie L, Good, Chester B, Zhao, Xinhua, Cunningham, Francesca E, Heron, Bernadette B, Geraci, Mark, Passero, Vida, Stone, Roslyn A, Smith, Kenneth J, Rogers, Renee, Shields, Jenna, Sartore, Megan, Boyle, D Patrick, Giberti, Sherry, Szymanski, John, Smith, Doug, Ha, Allen, Sessions, Jolynn, Depcinski, Shawn, Fishco, Shane, Molina, Irvin, Lepir, Tanja, Jean, Carmela, Cruz-Diaz, Lymaris, Motta, Jessica, Calderon-Vargas, Rebeca, Maland, Janelle, Keefe, Sean, Tague, Marshall, Leone, Alice, Glovack, Brian, Kaplan, Blair, Cosgriff, Sean, Kaster, Lindsay, Tonnu-Mihara, Ivy, Nguyen, Kimmai, Carmichael, Jenna, Clifford, Linda, Lu, Kan, Chatta, Gurkamal
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2015
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4352567/
https://ncbi.nlm.nih.gov/pubmed/25884851
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1038-y
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars